Brand-name Drug Prices Rising at Slower Pace, Lower Amounts – U.S. News & World Report via Associated Press

Read article - Continued coverage of comments by Adrienne Faerber, lecturer for The Dartmouth Institute for Health Policy and Clinical Practice, in an article about a study that found that drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to.